- Home
- GGT vs SRZN Comparison
GGT vs SRZN Comparison
Compare GGT & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GGT | SRZN |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.8M | 117.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GGT | SRZN |
|---|---|---|
| Price | $4.20 | $24.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $38.50 |
| AVG Volume (30 Days) | 59.7K | ★ 107.8K |
| Earning Date | 01-01-0001 | 11-07-2025 |
| Dividend Yield | ★ 15.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | N/A | ★ $3,604,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.90 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.32 | $5.90 |
| 52 Week High | $7.00 | $24.94 |
Technical Indicators
Market Signals| Indicator | GGT | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 55.69 | 85.00 |
| Support Level | $4.16 | $14.94 |
| Resistance Level | $4.32 | $24.86 |
| Average True Range (ATR) | 0.05 | 1.57 |
| MACD | 0.02 | 0.92 |
| Stochastic Oscillator | 59.09 | 97.12 |
Price Performance
Historical ComparisonAbout GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).